Marketing Experimental Stem Cell Therapies in the UK: Biomedical Lifestyle Products and the Promise of Regenerative Medicine in the Digital Era

The document analyzed the rise of direct-to-consumer experimental stem cell therapies in the UK, marketed as biomedical lifestyle products despite lacking scientific validation and approval from mainstream healthcare authorities. These therapies were promoted online, leveraging digital platforms to reach consumers directly, often blurring the lines between medical and aesthetic interventions. The study identified 71 UK businesses, primarily in London, marketing these therapies for conditions like anti-aging and musculoskeletal issues, using terms like "regenerative" and "rejuvenation." Concerns were raised about safety, efficacy, and the exploitation of patients, with calls for stronger regulation and a broader understanding of the socio-technological context. The marketing strategies capitalized on cultural aspirations and promissory narratives, challenging traditional scientific authority and emphasizing the need for better regulatory oversight.